Sarilumab is currently used to treat adult patients with moderately-to-severely active rheumatoid arthritis after treatment with at least 1 disease-modifying antirheumatic drug.
President Trump and his health advisors announced a 15-day plan to slow the spread of COVID-19.
Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
A clinical trial evaluating an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, has been launched, with volunteers receiving the first injection on March 16.
Telehealth advancements in response to COVID-19 reveal the importance of digital health delivery during outbreaks.
Walgreens, CVS Health, and Target said they will start providing coronavirus disease (COVID-19) testing in their parking lots.
An update on how COVID-19 is affecting pharmacy.
More than one-third of all children in the United States are not following the recommended vaccine schedule, according to a new study.
A new study examines why some individuals are able to fight off the flu better than others. The answer, in part, may lead back to childhood.
Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.